Skip to content

Tango Therapeutics

US · TNGX #2322 by market cap Listed 1970
21.73 -0.98 -4.32%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:41

About Tango Therapeutics

Tango Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in discovering and delivering precision cancer medicines. It also identifies novel targets and develops new drugs directed at tumor suppressor gene loss in defined patient populations with high unmet medical need. The company was founded by Alan Ashworth, William G. Kaelin Jr., Jose Baselga, Antoni Ribas and Barbara Weber in 2017 and is headquartered in Boston, MA.

Founded
2017
CEO
Dr. Malte Peters, M.D.
Employees
137
Headquarters
Boston, Massachusetts, United States of America
Fiscal year end
12-31
Website
tangotx.com

Company profile

Exchange
US
Symbol
TNGX
Market-cap rank
#2322
Listing date
1970-01-01
Market cap
3.68B
Float cap
3.11B
Shares out
169.46M
Float shares
143.08M

Sectors & themes

Browse all sectors & themes

Quote time 2026-11-20 19:41:45 · For reference only, not investment advice and not tailored to your situation.

Tango Therapeutics discussion 0 comments

Add a comment